- Home
- ACIU vs XYF Comparison
ACIU vs XYF Comparison
Compare ACIU & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- XYF
- Stock Information
- Founded
- ACIU 2003
- XYF 2014
- Country
- ACIU Switzerland
- XYF China
- Employees
- ACIU N/A
- XYF N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- XYF Finance: Consumer Services
- Sector
- ACIU Health Care
- XYF Finance
- Exchange
- ACIU Nasdaq
- XYF Nasdaq
- Market Cap
- ACIU 213.3M
- XYF 708.7M
- IPO Year
- ACIU 2016
- XYF 2018
- Fundamental
- Price
- ACIU $2.54
- XYF $14.04
- Analyst Decision
- ACIU Strong Buy
- XYF
- Analyst Count
- ACIU 2
- XYF 0
- Target Price
- ACIU $10.00
- XYF N/A
- AVG Volume (30 Days)
- ACIU 132.1K
- XYF 401.2K
- Earning Date
- ACIU 11-04-2025
- XYF 08-18-2025
- Dividend Yield
- ACIU N/A
- XYF 3.99%
- EPS Growth
- ACIU N/A
- XYF 41.77
- EPS
- ACIU N/A
- XYF 5.32
- Revenue
- ACIU $36,362,036.00
- XYF $1,047,188,328.00
- Revenue This Year
- ACIU N/A
- XYF N/A
- Revenue Next Year
- ACIU $1,022.98
- XYF N/A
- P/E Ratio
- ACIU N/A
- XYF $2.64
- Revenue Growth
- ACIU 86.71
- XYF 45.10
- 52 Week Low
- ACIU $1.43
- XYF $4.73
- 52 Week High
- ACIU $3.98
- XYF $20.36
- Technical
- Relative Strength Index (RSI)
- ACIU 66.33
- XYF 44.35
- Support Level
- ACIU $2.12
- XYF $13.94
- Resistance Level
- ACIU $2.35
- XYF $14.60
- Average True Range (ATR)
- ACIU 0.13
- XYF 0.68
- MACD
- ACIU 0.04
- XYF -0.03
- Stochastic Oscillator
- ACIU 98.08
- XYF 27.82
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.